
|Videos|March 17, 2023
Emma Guttman-Yassky of Icahn School of Medicine Talks Developments in Atopic Dermatitis Treatment
Emma Guttman-Yassky, M.D., Ph.D. of Icahn School of Medicine at Mount Sinai, New York discussed developments in atopic dermatitis treatment, more specifically with therapies like rocatinlimab and other anti-OX4 agents today at the annual American Academy of Dermatology meeting in New Orleans.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
What NCCN’s next CMO sees ahead for cancer guidelines, access and innovation
2
Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis
3
A look back at 2025’s sunscreen controversy and confusion
4
2025 FDA added indications to dermatologic medications
5





















































